HQY vs GMED

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 10, 2026

HQY

41.7
AI Score
VS
GMED Wins

GMED

42.9
AI Score

Investment Advisor Scores

HQY

42score
Recommendation
HOLD

GMED

43score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric HQY GMED Winner
Revenue 705.37M 1.55B GMED
Net Income 135.06M 275.87M GMED
Net Margin 19.1% 17.8% HQY
Operating Income 201.64M 332.82M GMED
ROE 6.8% 5.8% HQY
ROA 4.1% 5.0% GMED
Total Assets 3.27B 5.49B GMED
Cash 256.00M 507.75M GMED
Current Ratio 2.99 4.62 GMED
Free Cash Flow 232.34M 339.32M GMED

Relative Price Performance (Last 90 Days)

HQY 1M: -8.8% · 3M: +8.2% GMED 1M: -13.4% · 3M: -7.9%

Current Technical Phase

HQY

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 45

RSI (14): 44.6 · Price: $96.26

GMED

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 32

RSI (14): 31.6 · Price: $74.19

Fundamentals Snapshot

Metric HQY GMED
Market Cap
Forward P/E 21.2 13.7
Trailing P/E 33.4 19.1
Revenue (TTM)
Revenue Growth 0.1% 0.1%
Gross Margin 0.7% 0.7%
Operating Margin 0.3% 0.2%
EPS 2.83 3.86
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, GMED is currently the stronger investment candidate, winning 8 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.